Article History
Received: 22 April 2020
Accepted: 30 April 2020
First Online: 8 May 2020
Ethics approval and consent to participate
: Not applicable
: Not applicable
: The following pending patents are relevant to the work in this manuscript:• PCT/EP2019/087056. L-triiodothyronine (T3) for use in limiting microvascular obstruction• Greek Patent Office, number of case: 22-0002577373. Composition comprising L-triiodothyronine (T3) for use in the treatment of critically ill patients with coronavirus infection.IT, managing director of Uni-Pharma, is the sponsor and owner of these patents. CP and IM are the inventors and hold royalties in relation to these patents.